Viemed Healthcare Inc Financials
Viemed Healthcare Inc (VMD) reported $301.6M in revenue over the twelve months to Jun 30, 2026, up 25.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Growth is being absorbed by heavier reinvestment, leaving operating cash generation stronger than post-investment cash generation.
By FY2025, operating cash flow was$51.9M while free-cash-flow margin was4.4% , showing that accounting cash generation is being heavily consumed by reinvestment. The business therefore produces cash before capital spending, but retains considerably less after funding the assets needed to support expansion.
Operating margin reached
Debt-to-equity was 0.1x in FY2025, so liabilities are not primarily debt-funded. Yet the current ratio fell from 2.7x in FY2021 to 1.2x in FY2025, meaning expansion has narrowed short-term balance-sheet slack even without heavy leverage.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Viemed Healthcare Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Viemed Healthcare Inc has an operating margin of 8.5%, meaning the company retains $8 of operating profit per $100 of revenue. This strong profitability earns a score of 70/100, reflecting efficient cost management and pricing power. This is up from 8.0% the prior year.
Viemed Healthcare Inc's revenue surged 20.5% year-over-year to $270.3M, reflecting rapid business expansion. This strong growth earns a score of 83/100.
Viemed Healthcare Inc carries a low D/E ratio of 0.08, meaning only $0.08 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.
Viemed Healthcare Inc's current ratio of 1.18 is below the typical benchmark, resulting in a score of 28/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Viemed Healthcare Inc has a free cash flow margin of 4.4%, earning a moderate score of 45/100. The company generates positive cash flow after capital investments, but with room for improvement.
Viemed Healthcare Inc earns a strong 10.9% return on equity (ROE), meaning it generates $11 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 80/100. This is up from 8.7% the prior year.
Viemed Healthcare Inc scores 6.12, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($335.2M) relative to total liabilities ($55.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Viemed Healthcare Inc passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Viemed Healthcare Inc generates $3.37 in operating cash flow ($51.9M OCF vs $15.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Viemed Healthcare Inc generated $270.3M in revenue in fiscal year 2025. This represents an increase of 20.5% from the prior year.
Viemed Healthcare Inc's EBITDA was $51.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.2% from the prior year.
Viemed Healthcare Inc reported $15.4M in net income in fiscal year 2025. This represents an increase of 35.1% from the prior year.
Viemed Healthcare Inc earned $0.37 per diluted share (EPS) in fiscal year 2025. This represents an increase of 32.1% from the prior year.
Cash & Balance Sheet
Viemed Healthcare Inc generated $11.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 805.2% from the prior year.
Viemed Healthcare Inc held $13.5M in cash against $11.3M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Viemed Healthcare Inc's gross margin was 57.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the prior year.
Viemed Healthcare Inc's operating margin was 8.5% in fiscal year 2025, reflecting core business profitability. This is up 0.5 percentage points from the prior year.
Viemed Healthcare Inc's net profit margin was 5.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.6 percentage points from the prior year.
Viemed Healthcare Inc's ROE was 10.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.2 percentage points from the prior year.
Capital Allocation
Viemed Healthcare Inc invested $3.0M in research and development in fiscal year 2025. This represents a decrease of 1.7% from the prior year.
Viemed Healthcare Inc spent $13.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Viemed Healthcare Inc invested $40.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 5.9% from the prior year.
VMD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78.1M+3.6% | $75.4M-1.0% | $76.2M+5.9% | $71.9M+14.0% | $63.1M+6.6% | $59.1M-2.6% | $60.7M+4.6% | $58.0M |
| Cost of Revenue | $33.0M+1.4% | $32.6M+1.6% | $32.1M+4.9% | $30.6M+16.1% | $26.3M+1.8% | $25.9M+5.3% | $24.6M+3.9% | $23.6M |
| Gross Profit | $45.0M+5.2% | $42.8M-2.9% | $44.1M+6.7% | $41.3M+12.6% | $36.7M+10.4% | $33.3M-7.9% | $36.1M+5.1% | $34.4M |
| R&D Expenses | $504K-13.0% | $579K-3.2% | $598K-22.8% | $775K-8.5% | $847K+6.3% | $797K-0.7% | $803K+6.1% | $757K |
| SG&A Expenses | $37.1M+6.7% | $34.8M+8.0% | $32.2M+0.9% | $31.9M+10.8% | $28.8M+1.3% | $28.4M+0.8% | $28.2M+5.8% | $26.7M |
| Operating Income | $4.5M+3.8% | $4.3M-48.7% | $8.4M+48.4% | $5.6M+10.7% | $5.1M+32.6% | $3.8M-40.5% | $6.5M+14.6% | $5.6M |
| Interest Expense | $248K-18.7% | $305K | N/A | N/A | $132K-26.3% | $179K | N/A | N/A |
| Income Tax | $1.2M-9.9% | $1.3M-41.7% | $2.2M+42.7% | $1.5M-10.4% | $1.7M+79.9% | $952K-49.4% | $1.9M+18.0% | $1.6M |
| Net Income | $2.8M+7.0% | $2.6M-57.7% | $6.1M+73.8% | $3.5M+11.3% | $3.2M+20.3% | $2.6M-41.0% | $4.5M+14.8% | $3.9M |
| EPS (Diluted) | $0.07+16.7% | $0.06-57.1% | $0.14+55.6% | $0.09+12.5% | $0.08+33.3% | $0.06-45.5% | $0.11+10.0% | $0.10 |
VMD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $204.2M+3.5% | $197.4M-0.9% | $199.2M-1.6% | $202.4M+9.6% | $184.6M+3.7% | $178.1M+0.6% | $177.1M+4.4% | $169.5M |
| Current Assets | $54.0M+8.3% | $49.8M+2.7% | $48.5M-3.0% | $50.0M-9.6% | $55.3M+12.6% | $49.1M-7.1% | $52.9M+10.9% | $47.7M |
| Cash & Equivalents | $10.7M+9.4% | $9.8M-27.7% | $13.5M+21.4% | $11.1M-44.4% | $20.0M+97.0% | $10.2M-42.1% | $17.5M+54.6% | $11.3M |
| Inventory | $5.3M+1.6% | $5.2M+2.7% | $5.0M-4.2% | $5.3M+21.9% | $4.3M-4.1% | $4.5M+4.4% | $4.3M+0.2% | $4.3M |
| Accounts Receivable | $32.2M+3.4% | $31.2M+21.9% | $25.6M-6.7% | $27.4M+3.3% | $26.5M-0.9% | $26.8M+7.5% | $24.9M-7.9% | $27.1M |
| Goodwill | $58.9M0.0% | $58.9M0.0% | $58.9M+0.8% | $58.5M+77.2% | $33.0M0.0% | $33.0M0.0% | $33.0M0.0% | $33.0M |
| Total Liabilities | $58.3M+13.0% | $51.6M-7.3% | $55.6M-16.8% | $66.9M+55.6% | $43.0M+4.0% | $41.3M-5.6% | $43.8M+2.4% | $42.7M |
| Current Liabilities | $47.9M+17.7% | $40.7M-0.9% | $41.1M-7.1% | $44.2M+18.6% | $37.3M+5.0% | $35.5M-4.9% | $37.3M+2.4% | $36.4M |
| Long-Term Debt | $6.4M-23.5% | $8.3M-26.2% | $11.3M-42.3% | $19.6M+465.2% | $3.5M-1.8% | $3.5M-1.6% | $3.6M-1.7% | $3.6M |
| Total Equity | $144.0M+0.1% | $143.9M+1.6% | $141.5M+5.9% | $133.6M-4.4% | $139.7M+3.7% | $134.8M+2.6% | $131.4M+5.1% | $125.0M |
| Retained Earnings | $108.2M+2.6% | $105.5M+2.5% | $102.9M+5.8% | $97.3M+3.6% | $93.8M+3.4% | $90.7M+1.2% | $89.7M+5.1% | $85.4M |
VMD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.9M+97.0% | $8.1M-56.2% | $18.4M+0.4% | $18.4M+49.9% | $12.3M+329.4% | $2.9M-81.0% | $15.0M+17.6% | $12.7M |
| Capital Expenditures | $8.5M+26.0% | $6.7M-23.2% | $8.7M+14.4% | $7.6M-6.1% | $8.1M-47.5% | $15.5M+30.9% | $11.8M+7.5% | $11.0M |
| Free Cash Flow | $7.4M+447.6% | $1.4M-86.0% | $9.7M-9.6% | $10.7M+160.1% | $4.1M+132.7% | -$12.6M-499.9% | $3.2M+81.2% | $1.7M |
| Investing Cash Flow | -$7.8M-42.9% | -$5.5M+27.9% | -$7.6M+76.4% | -$32.3M-1770.1% | -$1.7M+79.8% | -$8.5M+7.3% | -$9.2M-85.1% | -$5.0M |
| Financing Cash Flow | -$7.1M-13.0% | -$6.3M+25.2% | -$8.5M-267.8% | $5.0M+850.7% | -$671K+60.6% | -$1.7M-521.8% | $404K+107.7% | -$5.2M |
| Share Buybacks | $5.3M+269.8% | $1.4M | $0-100.0% | $11.6M+594.8% | $1.7M | $0 | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
VMD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.7%+0.9pp | 56.8%-1.1pp | 57.9%+0.4pp | 57.5%-0.8pp | 58.3%+2.0pp | 56.3%-3.3pp | 59.5%+0.3pp | 59.3% |
| Operating Margin | 5.7%0.0pp | 5.7%-5.3pp | 11.0%+3.1pp | 7.8%-0.2pp | 8.1%+1.6pp | 6.5%-4.1pp | 10.6%+0.9pp | 9.7% |
| Net Margin | 3.5%+0.1pp | 3.4%-4.6pp | 8.0%+3.1pp | 4.9%-0.1pp | 5.0%+0.6pp | 4.4%-2.9pp | 7.3%+0.6pp | 6.7% |
| Return on Equity | 1.9%+0.1pp | 1.8%-2.5pp | 4.3%+1.7pp | 2.6%+0.4pp | 2.3%+0.3pp | 1.9%-1.4pp | 3.4%+0.3pp | 3.1% |
| Return on Assets | 1.4%0.0pp | 1.3%-1.8pp | 3.1%+1.3pp | 1.7%0.0pp | 1.7%+0.2pp | 1.5%-1.0pp | 2.5%+0.2pp | 2.3% |
| Current Ratio | 1.13-0.1x | 1.220.0x | 1.18+0.1x | 1.13-0.4x | 1.48+0.1x | 1.380.0x | 1.42+0.1x | 1.31 |
| Debt-to-Equity | 0.040.0x | 0.060.0x | 0.08-0.1x | 0.15+0.1x | 0.020.0x | 0.030.0x | 0.030.0x | 0.03 |
| FCF Margin | 9.5%+7.7pp | 1.8%-10.9pp | 12.7%-2.2pp | 14.9%+8.4pp | 6.5%+27.9pp | -21.4%-26.6pp | 5.2%+2.2pp | 3.0% |
Similar Companies
Where Viemed Healthcare Inc Ranks
Frequently Asked Questions
What is Viemed Healthcare Inc's annual revenue?
Viemed Healthcare Inc (VMD) reported $270.3M in total revenue for fiscal year 2025. This represents a 20.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Viemed Healthcare Inc's revenue growing?
Viemed Healthcare Inc (VMD) revenue grew by 20.5% year-over-year, from $224.3M to $270.3M in fiscal year 2025.
Is Viemed Healthcare Inc profitable?
Yes, Viemed Healthcare Inc (VMD) reported a net income of $15.4M in fiscal year 2025, with a net profit margin of 5.7%.
What is Viemed Healthcare Inc's EBITDA?
Viemed Healthcare Inc (VMD) had EBITDA of $51.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Viemed Healthcare Inc have?
As of fiscal year 2025, Viemed Healthcare Inc (VMD) had $13.5M in cash and equivalents against $11.3M in long-term debt.
What is Viemed Healthcare Inc's gross margin?
Viemed Healthcare Inc (VMD) had a gross margin of 57.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Viemed Healthcare Inc's operating margin?
Viemed Healthcare Inc (VMD) had an operating margin of 8.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Viemed Healthcare Inc's net profit margin?
Viemed Healthcare Inc (VMD) had a net profit margin of 5.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Viemed Healthcare Inc's return on equity (ROE)?
Viemed Healthcare Inc (VMD) has a return on equity of 10.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Viemed Healthcare Inc's free cash flow?
Viemed Healthcare Inc (VMD) generated $11.9M in free cash flow during fiscal year 2025. This represents a 805.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Viemed Healthcare Inc's operating cash flow?
Viemed Healthcare Inc (VMD) generated $51.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Viemed Healthcare Inc's total assets?
Viemed Healthcare Inc (VMD) had $199.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Viemed Healthcare Inc's capital expenditures?
Viemed Healthcare Inc (VMD) invested $40.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Viemed Healthcare Inc spend on research and development?
Viemed Healthcare Inc (VMD) invested $3.0M in research and development during fiscal year 2025.
What is Viemed Healthcare Inc's current ratio?
Viemed Healthcare Inc (VMD) had a current ratio of 1.18 as of fiscal year 2025, which is considered adequate.
What is Viemed Healthcare Inc's debt-to-equity ratio?
Viemed Healthcare Inc (VMD) had a debt-to-equity ratio of 0.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Viemed Healthcare Inc's return on assets (ROA)?
Viemed Healthcare Inc (VMD) had a return on assets of 7.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Viemed Healthcare Inc's Altman Z-Score?
Viemed Healthcare Inc (VMD) has an Altman Z-Score of 6.12, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Viemed Healthcare Inc's Piotroski F-Score?
Viemed Healthcare Inc (VMD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Viemed Healthcare Inc's earnings high quality?
Viemed Healthcare Inc (VMD) has an earnings quality ratio of 3.37x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Viemed Healthcare Inc?
Viemed Healthcare Inc (VMD) scores 66 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.